title: Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy.
authors.forename: Antonia
authors.initials: A
authors.lastname: Bouts
authors.forename: Leo
authors.initials: L
authors.lastname: Monnens
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Davin
authors.forename: Geertrude
authors.initials: G
authors.lastname: Struijk
authors.forename: Lodewijk
authors.initials: L
authors.lastname: Spanjaard
mesh_terms: D000293:Adolescent; D000328:Adult; D000375:Aging / Q000502:physiology; D000743:Anemia, Hemolytic / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D022401:Meningococcal Vaccines / Q000008:administration & dosage / Q000627:therapeutic use*; D009345:Neisseria meningitidis / Q000145:classification / Q000276:immunology*; D038541:Neisseria meningitidis, Serogroup B / Q000276:immunology; D055815:Young Adult
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D022401:Meningococcal Vaccines; C481642:eculizumab